Study guide

9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management

Key Takeaways Explain This Topic AI

ICU delirium occurs in up to 70% of critically ill burn patients and represents an independent predictor of increased mortality, prolonged mechanical ventilation, self-extubation, autograft loss from accidental excoriation, and persistent long-term cognitive impairment (PICS).

Delirium presents in three distinct clinical motoric subtypes: Hyperactive (agitated, combative, hallucinating), Hypoactive ('quiet delirium'—lethargic, flat, withdrawn, accounting for >50% of cases and carrying the worst prognosis), and Mixed delirium.

Routine validated screening using the Confusion Assessment Method for the ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist (ICDSC) is mandatory at least every 8 to 12 hours; CAM-ICU positivity requires acute onset/fluctuating course (Feature 1), inattention (Feature 2), AND either altered level of consciousness (Feature 3) OR disorganized thinking (Feature 4).

Implementation of the multidisciplinary ABCDEF bundle (Assess/treat pain, Both SAT and SBT, Choice of sedation avoiding benzodiazepines, Delirium assessment/management, Early mobility, and Family engagement) is the single most effective evidence-based strategy to prevent and treat ICU delirium.

Antipsychotics (e.g., quetiapine, haloperidol, olanzapine) do not decrease delirium duration or ICU mortality and must be reserved strictly for severe, distressing hallucinations or uncontrollable agitation that threatens patient safety or graft survival; continuous QTc interval surveillance is mandatory.

Last updated: August 2026

9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management

Core Knowledge: Delirium is an acute, fluctuating organic brain dysfunction characterized by disturbances in attention, awareness, and baseline cognition. In the burn intensive care unit, delirium affects up to 50% to 70% of critically ill patients . Far from being an expected, benign consequence of critical illness, delirium is an independent predictor of 6-month mortality, prolonged mechanical ventilation, profound long-term cognitive impairment, and catastrophic surgical failure resulting from patients tearing off dressings and avulsing skin autografts.

1. Pathophysiology and Burn-Specific Delirium Risk Factors

The pathogenesis of burn delirium is multifactorial, involving neuroinflammation, microglial activation, blood-brain barrier (BBB) hyperpermeability, neurotransmitter dysregulation (acetylcholine deficiency and excess dopamine/glutamate), and cerebral microvascular hypoperfusion. NEUROBIOLOGY OF BURN ICU DELIRIUM

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ Major Burn Trauma (≥20% TBSA) / Sepsis / Inhalation Injury / Shock │
  • │ │ │
  • │ ▼ │
  • │ Massive Systemic Cytokine Surge: Circulating TNF-α, IL-1β, IL-6, IL-8 │
  • │ │ │
  • │ ▼ │
  • │ Breakdown of Blood-Brain Barrier (BBB) & Direct Microglial Activation │
  • │ │ │
  • │ ▼ │
  • │ Central Neurotransmitter Imbalance: Acetylcholine Depletion & Dopamine │
  • │ Excess ──► Cortical Network Breakdown & Severe Bioenergetic Failure │
  • │ │ │
  • │ ▼ │
  • │ ACUTE ORGANIC BRAIN DYSFUNCTION (ICU DELIRIUM) │
  • └────────────────────────────────────────────────────────────────────────┘

Multifactorial Delirium Risk Matrix in Burn Patients:

Modifiable Risk Factors Non-Modifiable / Baseline Risk Factors Burn-Specific / Iatrogenic Risk Factors

  • Continuous Benzodiazepine infusions ; • High-dose opioid exposure; • Physical wrist/ankle restraints; • Uncontrolled severe somatic pain; • Sleep fragmentation & sensory overload; • Electrolyte derangements ( N a + , K + , C a 2 + , M g 2 + Na^+, K^+, Ca^{2+}, Mg^{2+} N a + , K + , C a 2 + , M g 2 + ); • Untreated hypoxemia / hypercapnia • Advanced age ( ≥ 65 years \ge 65\text{ years} ≥ 65 years ); • Pre-existing cognitive impairment / dementia; • Baseline history of chronic alcohol / substance abuse; • Pre-existing psychiatric comorbidities (depression, PTSD); • Chronic renal or hepatic disease • High %TBSA thermal injury ( ≥ 30 % \ge 30\% ≥ 30% TBSA); • Concomitant toxic inhalation injury (CO / Cyanide); • Severe burn hypermetabolic catabolism; • Sepsis & invasive burn wound infection; • Prolonged mechanical ventilation; • Multiple surgeries with general anesthesia; • Prolonged immobilization & joint contractures

2. Clinical Motoric Subtypes of Delirium

Delirium is categorized into three clinical subtypes based on psychomotor activity. Recognizing the subtype is vital because clinical presentation dictates diagnostic vigilance and management. MOTORIC SUBTYPES OF ICU DELIRIUM

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ 1. HYPOACTIVE DELIRIUM ("Quiet Delirium") — Most Common (~50–60%) │
  • │ • Presentation: Lethargic, flat affect, withdrawn, staring, delayed │
  • │ verbal responses, decreased spontaneous motor activity. │
  • │ • Clinical Pitfall: Frequently missed; misdiagnosed as depression, │
  • │ fatigue, or 'good ICU sleep'. CARRIES THE HIGHEST MORTALITY. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 2. HYPERACTIVE DELIRIUM — (~10–15%) │
  • │ • Presentation: Agitated, combative, paranoid, restless, climbing │
  • │ out of bed, pulling invasive lines/tubes, visual hallucinations. │
  • │ • Clinical Impact: Immediate danger to self, graft avulsion risk. │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 3. MIXED DELIRIUM — (~25–35%) │
  • │ • Presentation: Rapid, unpredictable fluctuations between │
  • │ hyperactive combativeness and hypoactive lethargy within 24 hours. │
  • └────────────────────────────────────────────────────────────────────────┘
  • 3. Validated Delirium Screening Tools: CAM-ICU & ICDSC

Bedside nursing screening must be conducted routinely at least every 8 to 12 hours (every shift) and with any acute change in mental status. The two gold-standard, validated screening tools are the Confusion Assessment Method for the ICU (CAM-ICU) and the Intensive Care Delirium Screening Checklist (ICDSC) . CAM-ICU ASSESSMENT ALGORITHM AT THE BEDSIDE

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ STEP 1: Assess Level of Consciousness (RASS) │
  • │ • If RASS is -4 (deep sedation) or -5 (unarousable): STOP. Patient is │
  • │ UNTOUCHABLE / UNABLE TO ASSESS (UTA). Re-evaluate when lighter. │
  • │ • If RASS is ≥ -3 (-3 to +4): PROCEED to Step 2. │
  • └───────────────────────────────────┬────────────────────────────────────┘
  • │
  • ▼
  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ STEP 2: Evaluate Feature 1 — Acute Change or Fluctuating Course │
  • │ • Is there an acute change from baseline mental status? OR │
  • │ • Has the patient's mental status or RASS fluctuated in past 24 hours? │
  • └───────────────────────────────────┬────────────────────────────────────┘
  • │ YES (Required)
  • ▼
  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ STEP 3: Evaluate Feature 2 — Inattention │
  • │ • Squeeze hand on letter 'A' in 'S-A-V-E-A-H-A-A-R-T' (10 letters) │
  • │ • Errors > 2 (Missed 'A' or squeezed on non-'A')? │
  • └───────────────────────────────────┬────────────────────────────────────┘
  • │ YES (Required: >2 Errors)
  • ▼
  • ┌───────────────────┴───────────────────┐
  • │ │
  • ▼ ▼
  • ┌───────────────────────────────┐ ┌────────────────────────────────┐
  • │ Feature 3: Altered Level of │ │ Feature 4: Disorganized │
  • │ Consciousness │ OR │ Thinking │
  • │ • Is current RASS anything │ │ • 4 logic questions + command │
  • │ other than 0 (Alert/Calm)? │ │ • Errors > 1? │
  • └───────────────┬───────────────┘ └────────────────┬───────────────┘
  • │ │
  • └───────────────────┬────────────────────┘
  • │ EITHER Feature 3 OR Feature 4 POSITIVE
  • ▼
  • ┌──────────────────────────────────┐
  • │ CAM-ICU POSITIVE (DELIRIUM) │
  • │ [Feature 1 + 2 + (3 OR 4)] │
  • └──────────────────────────────────┘

CAM-ICU Feature Breakdown:

Feature 1: Acute Onset or Fluctuating Course: Evidence of a sudden change in mental status from baseline or fluctuation over the previous 24 hours (e.g., fluctuating RASS scores).

Feature 2: Inattention (Auditory / Visual Testing): Read the 10-letter sequence "S-A-V-E-A-H-A-A-R-T" (or "A-B-A-D-A-B-A-A-Y-T"). Instruct the patient to squeeze your hand every time they hear the letter "A" . An error is scored if the patient fails to squeeze on "A" or squeezes on another letter. > 2 errors >2\text{ errors} > 2 errors indicates inattention .

Feature 3: Altered Level of Consciousness: Evaluated directly by the patient's current RASS score. Any score other than 0 (Alert and Calm) is positive (i.e., − 3 , − 2 , − 1 , + 1 , + 2 , + 3 , + 4 -3, -2, -1, +1, +2, +3, +4 − 3 , − 2 , − 1 , + 1 , + 2 , + 3 , + 4 ).

Feature 4: Disorganized Thinking: Administer 4 simple binary logic questions and a 2-step command:

1. Will a stone float on water?

2. Are there fish in the sea?

3. Does one pound weigh more than two pounds?

4. Can you use a hammer to pound a nail?

Command: "Hold up this many fingers" (examiner demonstrates 2 fingers), then "Now do the same with the other hand" (without demonstrating).

> 1 error >1\text{ error} > 1 error indicates disorganized thinking .

Intensive Care Delirium Screening Checklist (ICDSC):

An 8-item observational screening tool scored from 0 to 8 over a 24-hour shift:

Items: (1) Altered consciousness, (2) Inattention, (3) Disorientation, (4) Hallucinations/delusions, (5) Psychomotor agitation/retardation, (6) Inappropriate speech/mood, (7) Sleep-wake cycle disturbance, (8) Symptom fluctuation.

Scoring: ≥ 4 points \ge 4\text{ points} ≥ 4 points = Clinical Delirium ; 1 to 3 points = Subsyndromal Delirium (warrants early intervention).

4. The ABCDEF (PADIS) Bundle in Burn Care

The implementation of the evidence-based ABCDEF Bundle reduces delirium occurrence by up to 50%, shortens mechanical ventilation duration, decreases ICU readmission rates, and improves long-term survival. THE ABCDEF CARE BUNDLE IN BURNS

  • ┌───┬───────────────────────────────────┬────────────────────────────────────────┐
  • │ A │ Assess, Prevent, and Manage Pain │ Prioritize IV opioids/ketamine/multimod│
  • ├───┼───────────────────────────────────┼────────────────────────────────────────┤
  • │ B │ Both SAT and SBT Daily │ Spontaneous Awakening & Breathing trials│
  • ├───┼───────────────────────────────────┼────────────────────────────────────────┤
  • │ C │ Choice of Analgesia and Sedation │ Light sedation; AVOID BENZODIAZEPINES │
  • ├───┼───────────────────────────────────┼────────────────────────────────────────┤
  • │ D │ Delirium: Assess, Prevent, Manage │ Screen q8-12h with CAM-ICU / ICDSC │
  • ├───┼───────────────────────────────────┼────────────────────────────────────────┤
  • │ E │ Early Mobility and Exercise │ Physical/Occupational therapy on Day 1 │
  • ├───┼───────────────────────────────────┼────────────────────────────────────────┤
  • │ F │ Family Engagement and Empowerment │ Reorientation, photos, familiar voices │
  • └───┴───────────────────────────────────┴────────────────────────────────────────┘

Burn-Specific Execution Details:

A (Pain Management): Routine pain scoring with CPOT/BPS; preemptive procedural analgesia prior to wound debridement and dressing changes.

B (SAT / SBT Coordination): Daily cessation of sedatives ("sedation vacation") paired with ventilator weaning trials as soon as hemodynamic stability and airway parameters permit.

C (Sedation Choice): Prefer non-benzodiazepine agents (dexmedetomidine or propofol). Benzodiazepines (midazolam/lorazepam) are independent risk factors for delirium and must be avoided except for alcohol withdrawal.

D (Delirium Prevention & Environmental Management):

Reorientation: Position large-print clocks, updated calendars, and communication whiteboards in direct visual line.

Sensory Aids: Promptly replace patient's personal hearing aids and eyeglasses .

Restraint Reduction: Remove physical restraints as early as possible; restraints exacerbate hyperactive combativeness.

E (Early Mobility): Progressive physical rehabilitation starting within 24 hours of admission—in-bed active/passive range of motion, dangling at the edge of the bed, transfer to cardiac chair, and standing/ambulation with ventilator support.

F (Family Engagement): Involve family members in daily care rounds, reorientation protocols, reading familiar books, and playing preferred music.

5. Pharmacological Management of Severe Delirium and QTc Surveillance

Important

Clinical trials demonstrate that antipsychotic medications do NOT decrease the duration of delirium, shorten ICU stay, or reduce mortality . Antipsychotics must NEVER be used for routine delirium prophylaxis or for treating quiet, hypoactive delirium. They are indicated strictly as short-term rescue therapy for severe, intractable agitation, distressing hallucinations, or violent behavior that endangers patient safety or surgical graft integrity.

Pharmacological Options for Severe Refractory Delirium:

Atypical Antipsychotics (Second-Generation):

Quetiapine (Seroquel): 25 to 50 mg PO/NG every 12 hours (titrated up to 100–200 mg BID). Preferred in burn patients due to mild sedative properties and lower incidence of extrapyramidal symptoms.

Olanzapine (Zyprexa): 2.5 to 10 mg PO/IM/sublingual daily. Effective for severe agitation and concomitant nausea.

Typical Antipsychotics (First-Generation):

Haloperidol (Haldol): 0.5 to 2.5 mg IV/IM every 4 to 6 hours PRN for acute, dangerous combativeness. Has minimal active hemodynamic suppression but carries higher extrapyramidal risk.

Alpha-2 Agonists for Hyperactive Agitation:

Dexmedetomidine (Precedex): Highly effective in weaning mechanically ventilated patients who fail extubation trials purely due to hyperactive, hyperadrenergic delirium. CARDIAC SAFETY PROTOCOL: QTC SURVEILLANCE

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ Baseline 12-Lead ECG Prior to Initiating Any Antipsychotic Agent │
  • │ │ │
  • │ ▼ │
  • │ Calculate Bazett Corrected QT Interval: QTc = QT / sqrt(RR interval) │
  • │ • Normal QTc: Men < 450 ms; Women < 460 ms │
  • │ • Borderline / Caution: QTc 460–500 ms │
  • │ • HIGH RISK / CONTRAINDICATED: Baseline QTc > 500 ms │
  • │ │ │
  • │ ▼ │
  • │ Daily ECG & Continuous Telemetry Monitoring During Pharmacotherapy │
  • │ │ │
  • │ ▼ │
  • │ HOLD / DISCONTINUE ANTIPSYCHOTIC IF: │
  • │ [1] Absolute QTc exceeds 500 ms │
  • │ [2] QTc increases by >60 ms above patient's baseline │
  • │ [3] Occurrence of polymorphic ventricular ectopic beats │
  • │ │ │
  • │ ▼ │
  • │ PREVENT TORSADES DE POINTES: Maintain K+ > 4.0 mEq/L & Mg2+ > 2.0 mg/dL│
  • └────────────────────────────────────────────────────────────────────────┘